NDC product
PRISMASOL BK0/0/1.2
NDC 24571-113 · Vantive US Healthcare LLC
Key facts
| Product NDC | 24571-113 |
|---|---|
| Proprietary name | PRISMASOL |
| Nonproprietary name | magnesium chloride, lactic acid, sodium chloride, and sodium bicarbonate |
| Substances | MAGNESIUM CHLORIDE, LACTIC ACID, SODIUM CHLORIDE, SODIUM BICARBONATE |
| Dosage form | INJECTION |
| Route | INTRAVENOUS |
| Labeler | Vantive US Healthcare LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA021703 |
| Pharmacologic classes | Acidifying Activity [MoA], Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA] and 3 more |
| Marketing start | Oct 25, 2006 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: